Diminished clearance of soluble aggregates of human immunoglobulin G in patients with rheumatoid arthritis. 1989

S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
Department of Nephrology, University Hospital, Leiden, The Netherlands.

Investigation of the capacity of the mononuclear phagocyte system to remove immune complexes from the circulation was performed by the administration of 125I-labelled aggregates of human immunoglobulin G (AIgG) to patients with seropositive rheumatoid arthritis and healthy volunteers. It was found that the rate at which AIgG disappeared from the circulation was significantly prolonged in patients with RA, t1/2 61 +/- 49 min, versus 26 +/- 8 min in healthy volunteers (p less than 0.01). We were not able to establish a correlation between the t1/2 of AIgG and immune complex levels in the circulation, or between t1/2 and articular disease activity (Ritchie index). The sites of removal of AIgG from the circulation were analysed by determining radioactivity levels detectable over liver, spleen and heart. No correlation was found between t1/2 and liver/spleen uptake ratios. We have demonstrated that the removal of AIgG from the circulation of patients with RA is abnormal, though the biological significance of this finding remains to be determined.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
August 1987, The Journal of rheumatology,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
May 1993, Annals of the rheumatic diseases,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
March 1970, Annals of the rheumatic diseases,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
May 1991, Journal of clinical & laboratory immunology,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
August 2006, Human immunology,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
January 2005, Postepy higieny i medycyny doswiadczalnej (Online),
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
March 1996, The Biochemical journal,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
January 1979, The Journal of rheumatology,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
January 1984, Immunology,
S Lobatto, and M R Daha, and M L Westedt, and E K Pauwels, and J H Evers-Schouten, and A A Voetman, and A Cats, and L A van Es
May 1992, European journal of clinical investigation,
Copied contents to your clipboard!